Financials
- Market Capitalization 23.82 M
- Employee 11
- Founded 1996
- CEO N/A
- Website www.cellectar.com
- Headquarter Delaware, United States
- FIGI BBG000G9WFQ5
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.35
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4508 | GNTA Genenta Science S.p.A. - American Depositary Shares | 1.05 USD | +6.06% | -17.32% | -33.54% | -72.15% | 24.60 M USD | ||
| 4511 | TVRD Tvardi Therapeutics, Inc. - Common Stock | 1.81 USD | 0.00% | -2.16% | -26.42% | -49.72% | 24.14 M USD | ||
| 4516 | MRKR Marker Therapeutics, Inc. - Common Stock | 1.42 USD | -2.74% | +1.43% | +19.33% | +44.90% | 23.68 M USD | ||
| 4530 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 14.06 USD | -16.80% | +3.69% | +11.76% | +140.34% | 22.76 M USD |